NO864993D0 - 2-((3,5-dihalo-4-aminobenzyl))imidazoliner. - Google Patents

2-((3,5-dihalo-4-aminobenzyl))imidazoliner.

Info

Publication number
NO864993D0
NO864993D0 NO864993A NO864993A NO864993D0 NO 864993 D0 NO864993 D0 NO 864993D0 NO 864993 A NO864993 A NO 864993A NO 864993 A NO864993 A NO 864993A NO 864993 D0 NO864993 D0 NO 864993D0
Authority
NO
Norway
Prior art keywords
aminobenzyl
dihalo
imidazoline
Prior art date
Application number
NO864993A
Other languages
English (en)
Other versions
NO864993L (no
Inventor
Martin Winn
John Francis Debernardis
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO864993D0 publication Critical patent/NO864993D0/no
Publication of NO864993L publication Critical patent/NO864993L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO864993A 1985-12-11 1986-12-10 2-((3,5-dihalo-4-aminobenzyl))imidazoliner. NO864993L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/807,921 US4665095A (en) 1985-12-11 1985-12-11 Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion

Publications (2)

Publication Number Publication Date
NO864993D0 true NO864993D0 (no) 1986-12-10
NO864993L NO864993L (no) 1987-06-12

Family

ID=25197433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864993A NO864993L (no) 1985-12-11 1986-12-10 2-((3,5-dihalo-4-aminobenzyl))imidazoliner.

Country Status (9)

Country Link
US (1) US4665095A (no)
EP (1) EP0230532B1 (no)
JP (1) JPH07116038B2 (no)
AU (1) AU591740B2 (no)
CA (1) CA1282334C (no)
DE (1) DE3674569D1 (no)
FI (1) FI865025A (no)
NO (1) NO864993L (no)
NZ (1) NZ218334A (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
JP4096363B2 (ja) * 1997-03-14 2008-06-04 日本新薬株式会社 鼻又は眼の充血治療剤
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
AU3883099A (en) * 1998-05-06 1999-11-23 Duke University Method of treating bladder and lower urinary tract syndromes
RU2008130455A (ru) * 2006-01-27 2010-03-10 Ф.Хоффманн-Ля Рош Аг (Ch) Применение замещенных производных 2-имидазола или имидазолинов
AU2007312389B2 (en) * 2006-10-19 2012-02-23 F. Hoffmann-La Roche Ag Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
CN101528710B (zh) * 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 氨基甲基-4-咪唑类
EP2086959B1 (en) * 2006-11-02 2011-11-16 F. Hoffmann-La Roche AG Substituted 2-imidazoles as modulators of the trace amine associated receptors
CN101535298A (zh) * 2006-11-16 2009-09-16 弗·哈夫曼-拉罗切有限公司 取代的4-咪唑类化合物
CN101557810B (zh) * 2006-12-13 2012-11-21 弗·哈夫曼-拉罗切有限公司 作为痕量胺相关受体（taar）的配体的新的2-咪唑类
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
UA98951C2 (ru) 2007-02-02 2012-07-10 Ф. Хоффманн-Ля Рош Аг 2-аминооксазолины и лекарственное средство, которое их содержит
KR101222412B1 (ko) * 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
AU2008270445A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (TAARs)
WO2009003867A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
CA2694362A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
JP2010535172A (ja) * 2007-08-02 2010-11-18 エフ．ホフマン−ラ ロシュ アーゲー Ｃｎｓ障害の処置のためのベンズアミド誘導体の使用
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
US9381166B2 (en) * 2007-10-02 2016-07-05 Rigshospitalet Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
BRPI0916363A2 (pt) * 2008-07-24 2018-05-29 Hoffmann La Roche derivados de 4,5-di-hidro-oxazol-2-ila
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
MY195528A (en) 2016-03-17 2023-01-30 Hoffmann La Roche 5-Ethyl-4-Methyl-Pyrazole-3-Carboxamide Derivative Having Activity as Agonist of Taar
CN110944689B (zh) 2017-06-07 2022-12-09 施菲姆德控股有限责任公司 血管内流体运动设备、系统和使用方法
CN111556763B (zh) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 血管内流体运动装置、系统
EP3746149A4 (en) 2018-02-01 2021-10-27 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE AND METHODS OF MANUFACTURING
US11964145B2 (en) 2019-07-12 2024-04-23 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4034192A4 (en) 2019-09-25 2023-11-29 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMP SYSTEMS AND METHODS OF USE AND CONTROL THEREOF

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731471A (en) * 1956-01-17 Nxg hi
US2868802A (en) * 1959-01-13 Nxchj
DE1617618B2 (de) * 1966-06-18 1976-05-20 Merck Patent Gmbh, 6100 Darmstadt Schleimhautabschwellende mittel zur lokalen applikation
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
US3660423A (en) * 1970-02-13 1972-05-02 Dow Chemical Co 2-(substituted benzyl)methyl-2-imidazolines
US3922282A (en) * 1975-01-17 1975-11-25 American Home Prod 2-Aryl-2-imidazoline-1-propionic acids and their esters
AU1623483A (en) * 1978-02-01 1983-10-13 Wellcome Foundation Limited, The Formulations of imidazole derivatives
US4506074A (en) * 1982-11-08 1985-03-19 Merck & Co., Inc. 2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives
US4461914A (en) * 1983-02-01 1984-07-24 American Cyanamid Company Method for the preparation of 1-(4'-amino-3',5'-dichlorophenyl)-2-alkyl(or dialkyl)aminoethanols
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique

Also Published As

Publication number Publication date
FI865025A (fi) 1987-06-12
NO864993L (no) 1987-06-12
CA1282334C (en) 1991-04-02
AU6631986A (en) 1987-06-18
AU591740B2 (en) 1989-12-14
NZ218334A (en) 1989-03-29
JPS62145067A (ja) 1987-06-29
EP0230532B1 (en) 1990-09-26
EP0230532A1 (en) 1987-08-05
FI865025A0 (fi) 1986-12-10
JPH07116038B2 (ja) 1995-12-13
US4665095A (en) 1987-05-12
DE3674569D1 (de) 1990-10-31

Similar Documents

Publication Publication Date Title
NO864993D0 (no) 2-((3,5-dihalo-4-aminobenzyl))imidazoliner.
DE3577547D1 (de) 2-(2'-nitrobenzoyl)-1,3-cyclohexandionen.
FI861210A0 (fi) N,n'-dialkylguanidinodipeptider.
FI853193L (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
ATE38827T1 (de) Bestimmte 2-(2'-alkylbenzoyl)-1,3cyclohexandione.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
DE3775802D1 (de) 2-(4'-alkoxyphenyl)-5-alkylpyridine.
NL971040I2 (nl) 1-Dimethylcarbamoyl-3-gesubstitueerde-5-gesubstitueerde-1H-1,2,4-triazolen.
ATE45741T1 (de) 1-oxa-3-oxo-4,8-diaza-spiro-(4,5>decanverbindungen.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
DE3674054D1 (de) 1,3-disubstituierte imidazoliumsalze.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
DE3586745T2 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI863300A0 (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
FI861950A0 (fi) 1,3-dioxan-etrar.
DE3684900D1 (de) 2,2'-bi-1h-imidazole.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI865158A0 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
DE3586541T2 (de) 1,3-dithiol-2-ylidenderivate.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
DE3674284D1 (de) Kationische 1,2,3-thiadiazolazoverbindungen.
ATE61586T1 (de) 2-(arylbenzothiazin)-derivate.
DE3678154D1 (de) 2-(arylbenzothiazin)-derivate.
ATE45349T1 (de) Substituierte 2,3,4,9-tetrahydro-1h-carbazol-1essigs|urederivate.
NO892008L (no) Substituert 1,2,4-oksadiazol.